Skip to content
lifestyle.emphas.is
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Vicore Pharma Holding
Vicore Pharma Appoints Rob Slack as Chief Scientific Officer
July 6, 2026
Vicore Pharma to Commence Trading in the United States on the Nasdaq Stock Market
July 1, 2026
Vicore Pharma Elects Peter Guenter to its Board of Directors
May 7, 2026
Announcement from the Annual General Meeting of Vicore Pharma Holding AB (publ)
May 6, 2026
Interim Report January – March 2026
May 6, 2026
Vicore Pharma Announces Presentations at the 2026 American Thoracic Society International Conference
April 29, 2026
Vicore Pharma Completes Enrollment in the Phase 2b ASPIRE Trial of Buloxibutid in Idiopathic Pulmonary Fibrosis
April 22, 2026
Notice Of Annual General Meeting In Vicore Pharma Holding AB (PUBL)
April 1, 2026
Vicore Publishes the Annual Report for 2025
March 26, 2026
Vicore Pharma to Present at Upcoming Investor Conferences
March 9, 2026
1
2
Next Page
→